Status:

COMPLETED

A Study to Evaluate the Safety and Therapeutic Effects of Transplantation of MNV-BM-BLD in Pediatric Patients With Pearson Syndrome

Lead Sponsor:

Minovia Therapeutics Ltd.

Conditions:

Mitochondrial Diseases

Pearson Syndrome

Eligibility:

All Genders

3-18 years

Phase:

PHASE1

PHASE2

Brief Summary

Mitochondrial diseases are a genetically heterogeneous group of disorders caused by mutations or deletions in mitochondrial DNA (mtDNA) displaying a wide range of severity and phenotypes. These diseas...

Eligibility Criteria

Inclusion

  • Inclusion Criteria
  • Patient diagnosed with Pearson Syndrome, as verified by molecular identification of a defect in the mitochondrial DNA.
  • Normal maternal mitochondria as verified by mtDNA sequencing.
  • Males and females between 3 years or older and up to 18th birthday.
  • Patient is transfusion independent.
  • Patient has at least one of the following systematic involvements:
  • High baseline lactate levels
  • Episodes of metabolic crisis in the last year before pre-screening
  • Renal failure (not dependent on dialysis) or evidence of proximal tubulopathy
  • Growth retardation or failure to thrive
  • Exclusion Criteria
  • Absence of detectable mitochondria mutation or deletion.
  • Patient or patient's mother have a positive test for microbiologic
  • Patient is unable to undergo leukapheresis.
  • Patient suffers from chronic severe infection, malignant disease or any other disease or condition that may risk the patient or interfere with the ability to interpret the study results.
  • Patient has been treated previously with any cell or gene therapy.
  • Patient has participated in another clinical treatment trial or received other experimental medications outside of a clinical trial within 1 month prior to start of this study.

Exclusion

    Key Trial Info

    Start Date :

    February 13 2019

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    March 9 2021

    Estimated Enrollment :

    7 Patients enrolled

    Trial Details

    Trial ID

    NCT03384420

    Start Date

    February 13 2019

    End Date

    March 9 2021

    Last Update

    August 31 2021

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Sheba Medical Center Hospital- Tel Hashomer

    Ramat Gan, Israel